Field Trip Health Ltd. (TSE:FTRP – Get Free Report) shares traded up 5.8% on Monday . The stock traded as high as C$1.11 and last traded at C$1.09. 97,451 shares were traded during trading, an increase of 165% from the average session volume of 36,819 shares. The stock had previously closed at C$1.03.
Field Trip Health Price Performance
The firm has a market capitalization of C$12.68 million and a PE ratio of -1.22. The business’s 50-day moving average is C$1.09. The company has a current ratio of 8.20, a quick ratio of 7.70 and a debt-to-equity ratio of 43.39.
Field Trip Health Company Profile
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions.
Featured Articles
- Five stocks we like better than Field Trip Health
- 3 Healthcare Dividend Stocks to Buy
- Rocket Lab is the Right Stock for the Right Time
- What Investors Need to Know About Upcoming IPOs
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What is MarketRank™? How to Use it
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Field Trip Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Field Trip Health and related companies with MarketBeat.com's FREE daily email newsletter.
